The Novel Digital Diagnostic Approaches in Acromegaly and Sickle Cell Disease research grant from Pfizer supports research projects in the USA focusing on novel digital diagnostic approaches in patients with acromegaly or sickle cell disease. Projects that will be considered for Pfizer support will focus on digital diagnostic approaches to help raise suspicion and optimize care for patients with acromegaly or sickle cell disease. Projects may include but are not limited to Artificial Intelligence/Machine Learning approaches, facial recognition technology, smartphone-based applications, wearables, and/or virtual reality. Applicants must be based in the USA and affiliated with a host research institution.
Applicants may apply for up to 100,000 USD in funding support (including up to 28% of overheads).
Applications close on August 1, 2023.
August 1, 2023